1-3 of 3
Davide Radice, ST
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High Dose 90Yttrium Ibritumomab Tiuxetan with PBSC Support in Refractory-Resistant NHL Patients.

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Marta Cremonesi, MPh, Margherita Clerici, RN, Davide Radice, ST, Stefano Papi, PhD, Liliana Calabrese, DM, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2007) 110 (11): 1890.
https://doi.org/10.1182/blood.V110.11.1890.1890
Published: 2007
Journal Articles

High Dose 90 Yttrium Ibritumomab Tiuxetan (Zevalin) with PBSC Support in Refractory-Resistant NHL Patients: A Phase I/II Study.

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Marta Cremonesi, MPH, Margherita Clerici, RN, Davide Radice, ST, STefano Papi, Liliana Calabrese, DM, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2006) 108 (11): 2720.
https://doi.org/10.1182/blood.V108.11.2720.2720
Published: 2006
Journal Articles

Tissue Microarray (TMA) Study in DLBC Lymphomas (DLBCL): Could the Extranodal Origin Affect the Prognostic Impact of the Analysis?.

Daniele Laszlo, MD, Giancarlo Pruneri, MD, Giovanna Andreola, MD, Davide Radice, ST, Liliana Calabrese, DM, Alessandra Alietti, MD, Alberto Agazzi, MD, Anna Vanazzi, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2006) 108 (11): 2037.
https://doi.org/10.1182/blood.V108.11.2037.2037
Published: 2006